FINWIRES · TerminalLIVE
FINWIRES

Upbound Shares Fall After Q2 Non-GAAP Earnings Decline, Q3 Outlook Misses Estimates

By

Upbound Group (UPBD) shares were down more than 2% in Thursday trading after the company reported Q2 non-GAAP earnings of $1.07 per diluted share, down from $1.12 a year earlier.

Analysts polled by FactSet expected $1.05.

Revenue for the quarter ended June 30 was $1.16 billion, compared with $1.157 billion a year earlier.

Analysts expected $1.16 billion.

For Q3, the company expects non-GAAP diluted EPS of $0.85 to $0.95. Analysts expect $1.00. Revenue for the quarter is forecast at $1.05 billion to $1.15 billion. Analysts expect $1.19 billion.

Upbound maintained its 2026 non-GAAP diluted EPS outlook of $4.00 to $4.35, but narrowed its revenue guidance to between $4.7 billion and $4.85 billion, from prior outlook of $4.7 billion to $4.95 billion. Analysts expect $4.20 and $4.81 billion, respectively.

Price: $20.50, Change: $-0.45, Percent Change: -2.15%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT